Just before BioJapan 2025 takes over Pacifico Yokohama (Oct 8–10), another major event for diagnostics, JACLaS […]
Japan’s IVD sector remains highly structured and closely governed, benefiting from a mature healthcare infrastructure and […]
Japan is the fourth-largest global medical device market, with its healthcare system actively integrating digital tools […]
From Automation to Inflexion: AI’s Historical Trajectory in Pharma The pharmaceutical industry began its journey with […]
Navigating Japan’s life sciences sector successfully hinges on more than just excellent science or a meticulously […]
Is Japan’s Drug Pricing Squeeze Finally Loosening? Japan has long been a high-pressure pricing environment for […]
Japan has set ambitious goals to advance its bioeconomy, aiming to integrate biotechnology across various sectors […]
Advanced Therapy Medicinal Products (ATMPs) represent a rapidly evolving field in biotechnology, offering transformative therapeutic solutions […]
BioStock Global Forum 2024 – May 30, Part II Watch the keynote speech, including the Q&A […]
The healthcare industry is yet again undergoing a transformative phase. This time, let’s focus on the […]